William J Abrams
Insider
First SEC filing: Dec. 17, 2025 · Latest: June 17, 2026
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| June 15, 2026 | MDLN | F | 1,308 | $36.61 | $47,886 | 16,546 Direct | -7.33% | Disposed | -2.7% (price as of 2026-10-02) |
| March 5, 2026 | MDLN | A | 17,854 | · | · | 17,854 Direct | · | Acquired | (price as of 2026-10-02) |
| Dec. 16, 2025 | MDLN | A | 97,531 | · | · | 97,531 Indirect | · | Acquired | (price as of 2026-10-02) |
| Dec. 16, 2025 | MDLN | A | 91,078 | · | · | 91,078 Indirect | · | Acquired | (price as of 2026-10-02) |
| Dec. 16, 2025 | MDLN | A | 170,204 | · | · | 170,204 Indirect | · | Acquired | (price as of 2026-10-02) |
| Dec. 16, 2025 | MDLN | A | 1,129,447 | · | · | 1,129,447 Indirect | · | Acquired | (price as of 2026-10-02) |
| Dec. 16, 2025 | MDLN | A | 30,655 | · | · | 30,655 Indirect | · | Acquired | (price as of 2026-10-02) |
| Dec. 16, 2025 | MDLN | A | 495,680 | · | · | 495,680 Indirect | · | Acquired | (price as of 2026-10-02) |
| Dec. 16, 2025 | MDLN | A | 30,655 | · | · | 30,655 Indirect | · | Acquired | (price as of 2026-10-02) |
| Dec. 16, 2025 | MDLN | A | 495,680 | · | · | 495,680 Direct | · | Acquired | (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Dec. 16, 2025 | MDLN | Incentive Units of Medline Holdings, LP | Class A Common Stock | · | · | 97,531 | Acquired |
| Dec. 16, 2025 | MDLN | Incentive Units of Medline Holdings, LP | Class A Common Stock | · | · | 91,078 | Acquired |
| Dec. 16, 2025 | MDLN | Incentive Units of Medline Holdings, LP | Class A Common Stock | · | · | 170,204 | Acquired |
| Dec. 16, 2025 | MDLN | Incentive Units of Medline Holdings, LP | Class A Common Stock | · | · | 1,129,447 | Acquired |
| Dec. 16, 2025 | MDLN | Common Units of Medline Holdings, LP | Class A Common Stock | · | · | 30,655 | Acquired |
| Dec. 16, 2025 | MDLN | Common Units of Medline Holdings, LP | Class A Common Stock | · | · | 495,680 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 8 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Dec. 17, 2025 | MDLN | Class B Common Stock | 495,680 | Direct |
| Dec. 17, 2025 | MDLN | Class B Common Stock | 30,655 | Indirect |
| Dec. 17, 2025 | MDLN | Common Units of Medline Holdings, LP | 495,680 | Indirect |
| Dec. 17, 2025 | MDLN | Common Units of Medline Holdings, LP | 30,655 | Indirect |
| Dec. 17, 2025 | MDLN | Incentive Units of Medline Holdings, LP | 1,129,447 | Indirect |
| Dec. 17, 2025 | MDLN | Incentive Units of Medline Holdings, LP | 170,204 | Indirect |
| Dec. 17, 2025 | MDLN | Incentive Units of Medline Holdings, LP | 91,078 | Indirect |
| Dec. 17, 2025 | MDLN | Incentive Units of Medline Holdings, LP | 97,531 | Indirect |